Evidence map›Paper›PMID 31027178›Full record

ArticleInternational journal of molecular sciences2019

Theaflavin-Enriched Fraction Stimulates Adipogenesis in Human Subcutaneous Fat Cells.

Phil June Park, Chan-Su Rha, Sung Tae Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Research Progress in Skin Aging, Metabolism, and Related Products.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Theaflavin Chemistry and Its Health Benefits.Oxidative medicine and cellular longevity · 2021
    Review
  5. Complete chloroplast genome and phylogenetic analysis ofMitochondrial DNA. Part B, Resources · 2021
    Article
  6. Article
  7. Preventive Effects ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Phil June ParkBasic Research & Innovation Research Institute, AmorePacific Corporation R&D Unit., 1920, Yonggu-daero, Giheung-gu, Yongin-si, Gyeonggi-do 17074, Korea. philjunep@gmail.com.
Chan-Su RhaVital Beautie Research Institute, AmorePacific Corporation R&D Unit, 1920, Yonggu-daero, Giheung-gu, Yongin-si, Gyeonggi-do 17074, Korea. teaman@amorepacific.com.ORCID 0000-0003-4791-1314
Sung Tae KimDepartment of Pharmaceutical Engineering, Inje University, Gimhae-si 50834, Korea. stkim@inje.ac.kr.ORCID 0000-0001-8852-0198
Amorepacific (South Korea) · KRInje University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin provides the first defense line against the environment while preserving physiological homeostasis. Subcutaneous tissues including fat depots that are important for maintaining skin structure and alleviating senescence are altered during aging. This study investigated whether theaflavin (TF) in green tea (GT) has skin rejuvenation effects. Specifically, we examined whether high ratio of TF contents can induce the subcutaneous adipogenesis supporting skin structure by modulating lipid metabolism. The co-fermented GT (CoF-GT) fraction containing a high level of TF was obtained by co-fermentation with garland chrysanthemum (

Indexed as

AdipocytesAdipogenesisAdiponectinBiflavonoidsCatechinCell SurvivalChrysanthemumFermentationGene Expression RegulationHumansLipogenesisModels, BiologicalSubcutaneous FatAdiponectinBiflavonoidsCatechintheaflavinadipogenesisanti-aginggreen teahuman subcutaneous fat cellstheaflavin

Identifiers

PMID31027178
PMCPMC6515531
OpenAlexW2942483875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.